Probiotics and health

Asian Pacific Journal of Cancer Prevention

Volumn 4, Issue 4, 2003, Pages 369-372

  Ötles, Semih ^a   Çagindi, Özlem ^a   Akçiçek, Eren ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Bifidobacteria; Dairy food; Health; Lactobacilli; Probiotics

Indexed keywords

PROBIOTIC AGENT;

HUMAN; INTESTINE TUMOR; REVIEW;

HUMANS; INTESTINAL NEOPLASMS; PROBIOTICS;

EID: 1442284241     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Note

References (32)

1. Akali{dotless}n S and Otles S (2002). Beslenmede probiotiklerin önemi. Gida, 7, 70-4
2. Alm L (1982). Effect of fermentation on B-vitamin content of milk in Sweden. J Dairy Sci, 65, 353-9
3. Anon (2000). Probiotics - Friendly bacteria with a host of benefits. Dairy Council of California
4. Aso Y and Akazan H (1992). Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int, 49,125-9
5. De Vuyst L and Vandamme EJ (1994). Antimicrobial potential of lactic acid bacteria. In: De Vuyst L, Vandamme EL, (Eds) Bacteriocins of lactic acid bacteria. Glasgow, United Kingdom: Blackie Academic and Professional, p:91-142
6. Dugas B, Mercenier A, Wijnkoop LL, et al (2000). Immunity and probiotics. Trends Immunology Today, 20, 387-90
7. Fooks LJ and Gibson GR (2002). Probiotics as modulators of the gut flora. Br J Nutr, 88, 39-49
8. Friend BA and Shahani KM (1984). Nutritional and therapeutic aspects of lactobacilli. J Appl Nutr, 36, 125-53
9. Fujiwara S, Hashiba H, Hirota T, Forstner JF (1997). Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol, 63, 506-12
10. Fuller R (1992). History and development of probiotics. In Probiotics. The scientific basis. Chapman & Hall Publishers, London
11. Goldin BR, Gualtieri L, Moore RP (1996). The effect of Lactobacillus GG on the initiation and promotion of dimethylhydrazine-induced intestinal tumors in the rat. Nutr Cancer, 25,197-204
12. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T (1991). A human Lactobacillus strain (Lactobacillus casei sp. Strain GG) promotes recovery from acute diarrhea in children. Pediatrics, 88, 90-7
13. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T (1995). Improved immunogenicity of oral D 3 RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine, 13, 310-2
14. Kailasapathy K and Chin J (2000). Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol, 78, 80-8
15. Kopp-Hoolihan (2001). Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc, 101, 229-38
16. Langhendries JP, Detry J, Van Hees J (1995). Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr, 21, 177-81
17. Libbey J (1999). Functional Dairy Products. Nutrition and Health Collection
18. Mack DR, et al (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol, 276, 941-50
19. Metchnikoff E (1907). In The prolongation of life: optimistic studies, (Ed Chalmers Mitchell). London, William Heinemann
20. Miller HJMT (1996). Probiotics-panacea or nostrum? BNF Nutrition Bulletin, 21,199-202
21. Oksanen PJ, Salminen S, Saxelin M, et al (1990). Prevention of travelers' diarrhea by Lactobacillus GG. Ann Med, 22, 53-6
22. Rao CV, Sanders ME, Indranie C, Simi B, Reddy BS (1999). Prevention of indices of colon carcinogenesis by the probiotic Lactobacillus acidophilus NCFM [TM] in rats. Int J Oncol, 14 939-44
23. Reddy BS and Rivenson A (1993). Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo [4,5] quinoline, a food mutagen. Canc Res, 53, 3914-8
24. Robinson RK (1989). Special yogurts-the potential health benefits. Dairy Industries International, 54, 23-5
25. Rolfe RD (2000). The role of probiotic cultures in the control of gastrointestinal health. J Nufr, 130, 396-402
26. Salminen S, Isolauri E, Salminen E (1996). Clinical uses of probiotics for stablising gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek, 70, 347-58
27. Salji J (1994). Foods for the future. Food Science and Technology Today, 8,139-43
28. Shahani KM, Chandan RC (1979). Nutritional and healthful aspects of cultured and culture-containing dairy foods. J Dairy Sci, 62 1685-94
29. Siitonen S, Vapaatalo H, Salminen S, (1990). Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med, 22, 57-9
30. Steer T, et al (2000). Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Revs, 13, 229-54
31. Tuohy KM, Probert HM, Smejkal CW, Gibson GR (2003). Using probiotics and prebiotics to improve gut health. Reviews Therapeutic Focus, 8, 692-700
32. Wollowski I, Rechkemmer G, Pool-Zobel BL (2001). Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr, 73, 451-5